why choose us

First received: January 26, 2023

Clinical Trial: A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Head and Neck Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors

Brief Summary: The goal of this clinical trial is to test a new drug plus standard treatment compared with standard treatment alone in patients with advanced head and neck squamous cell carcinoma and cholangiocarcinoma.The main questions it aims to answer are:is the new drug plus standard treatment safe and tolerableis the new drug plus standard treatment more effective than standard treatment

Read more